Ocean Grown Abalone Dives Into ASX IPO
The head of WA nickel producer Panoramic Resources, Peter Harold is now watching more commodity prices than just the metals index.
Read More
Change Financial Quits Monkeying Around
What’s in a corporate name – or in this case a symbol?
Read MoreStargroup Sees ATM Opportunity
The only pure-play, ASX-listed ATM operator, Stargroup sniffs an opportunity in the big banks’ decision to abolish foreign ATM fees at an estimated collective cost to their revenue of $120m a year.
Read MoreTwo Small Caps With A ‘Hire’ Purpose
Schrole Group (SCL) not yet listed
Read MoreMerger The Ideal Packaged Solution
Manufacturing isn’t dead in Australia: it’s just employing far fewer workers.
Read MoreCannPal Prepares To Bring Pot To Pets
The latest aspirant to the bulging listed medical cannabis sector is bow-wow-wowing to a new trend of developing veterinary drugs over human therapies. But there are regulatory implications for all the pot stocks.
Read MoreTwo Small Caps For Artificial Intelligence Investors
SenSen Networks (not yet listed)
Read MoreStocks In The Baby-Making Business
A pregnant pause, or the advent of a more permanent decline?
Read MoreCertainty In Invocare, But Earnings Growth?
In the circle of life, every organic being must die and that makes the country’s dominant funeral and crematoria provider the ultimate defensive stock.
Read MorePharmAust Points The Bone At Cancer
There are plenty of cases of human drugs being repurposed for veterinary use, but not so much the other way around. That makes PharmAust different to other early stage drug developers as it targets cancer treatments for both people and their four-legged friends.
Read MoreAnatara Investors Look To Pig Out
Porkers of the world rejoice! If Anatara’s drug rollout goes to plan, soon their short lives in the sty will be healthier and just that little bit longer.
Read MoreMyFiziq On The Hunt For Financial Health
The last thing your columnist wants to know is the true gruesome extent of his middle age spread, but there are plenty of exponents of the body beautiful who want an accurate measure of weight loss.
Read MoreMayur Sands Come To The Market
In a variation of the coals-to-Newcastle theme, this eclectic multi-commodity resource house plans to ship one million tonnes of sand from PNG to Sydney.
Read MoreWhich Other Bank?
Which bank is the most “unquestionably strong” of its ASX-listed cohorts on a capital adequacy basis and also produces the highest net interest margins and sector-leading lending growth?
Read MoreResapp Searches For Remedy
The best-performing ASX stock of 2015, ResApp has joined the list of biotech stocks suffering an embarrassing – and surprising – clinical setback.
Read MoreWater Merger In Search Of Fluency
Speaking of water, about the only Australian aspect of the globalized, New York headquartered Fluence (formerly Emefcy) is it happens to be listed on the ASX.
Read MoreCropLogic Plants IPO Seed
A feature of this upcoming agrarian IPO is that unlike the last several hundred small-cap tech listings, it’s not being spruiked as a ‘cloud’ or ‘software as a service’ based offering or a robotics story.
Read MoreTwo Small Cap Power Plays
Northern Cobalt (not yet listed) The latest cobalt offering is testing ongoing investor appetite for the battery ingredient, in a climate in which investors are becoming more educated and more discerning about battery wonder metals and blue-sky promises.
Read MoreDefend Your Portfolio With These Small Caps
For a company that promotes itself as a homeland security specialist, life should be rosy as authorities spend up big on anything from protective bollards to bazookas.
Read MoreScouring The Silver Sector
In what’s not so much a case of Hi Ho Silver as “oh no!” silver, the grey metal has slumped on global markets after a couple of largely unexplained ‘flash crashes’ including a 7% dumping on July 7.
Read MoreHealth Check On 1st Group
First Group chief Klaus Bartosch says the health services portal’s share price “does not remotely reflect our performance.”
Read MoreCaterpillar Backs Bricklaying Robot
The robotics innovator is on the noblest of human quests: to eliminate the scourge of brickie’s crack from building sites globally.
Read MorePolitical Heavies Lose Big On Biotech
Innate chief Simon Wilkinson put it succinctly after the multiple sclerosis developer’s phase-two trial bombed out, spurring a share sell off that wiped off 90% of the company’s value in a matter of minutes.
Read MoreRedflex Hits A Speedbump
Just as the traffic camera operator looked to be “moving forward” – obeying all speed limits and red lights of course – along comes another snafu for the strife-prone company.
Read MoreAlderan & Golden Mile Drill Investors
We wouldn’t describe demand for new junior resource listings as effervescent, but this duo has made it to the starting line despite June being more of a time to shed dud scrip rather than take on new speccie plays.
Read MoreSyrah Moves From Explorer To Miner
After five years of speculative hype, the ASX-listed graphite sector is about to come of age with sector big daddy Syrah poised to start production at its massive Balama mine in Mozambique.
Read MoreCT1 Shortens The Odds On Food Safety
When Terry the cook from Fawlty Towers said “what the eye don’t see the chef gets away with”, he was oblivious to the enormous business risks posed by food contamination.
Read MoreConnecting The Dots On Veriluma
Just as we got used to the notion of big data analysis, along comes a tool that doesn’t even need hard numbers to analyse and predict a particular situation.
Read MoreEagle Health Eyes China Vitamin Boost
It’s tempting to view this one as a miniature Chinese version of nutraceuticals group Blackmores or the privately owned Suisse – because it is.
Read MoreHealthy Reception For Oliver’s IPO
The health food evangelist behind this impending listing faces a (literally) heavyweight task: weaning truckies and travelling families at roadside stops from fried dim sims to chia pods, pita pockets and green beans served in a French-fries style packet.
Read MoreWhat’s The Deal With Pot Stocks?
With the ASX-listed cannabis sector in a sharp retreat since late March, some investors are wondering whether they’re seeing the bourse’s equivalent of Fidget Spinners – those finger-held gadgets infiltrating playgrounds in the same way as marbles and Yo-Yos all those years ago.
Read MoreUncovering Value In Rox
Rox chief Ian Mulholland is perplexed why the WA gold and nickel explorer’s market valuation is less than it was last October, just before the company said it would sell its Reward zinc tenement in the NT for $20m cash.
Read MoreMareterram No Raw Prawn
At the risk of coming the raw prawn with investors, the WA-based fishing operator presents its own sums as to why the worth of its fishing licences alone justifies its market valuation.
Read More
